ClinicalTrials.govpublic full text
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ovarian cancer, primary peritoneal cavity cancer, recurrent ovarian epithelial cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 860678
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.